NCT03333486 2025-07-04Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood CancerRoswell Park Cancer InstitutePhase 2 Terminated31 enrolled 18 charts
NCT05315908 2024-02-28COVID-19 Testing in Underserved and Vulnerable PopulationsUniversity of California, San DiegoPhase NA Terminated9,120 enrolled 8 charts
NCT03733249 2023-09-26Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT03387033 2021-03-01Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)Duke UniversityPhase NA Terminated20 enrolled 9 charts
NCT01179217 2020-08-19A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemiaEmmaus Medical, Inc.Phase 3 Completed230 enrolled 19 charts 1 FDA
NCT01895361 2020-01-31SUSTAINReprixys Pharmaceutical CorporationPhase 2 Completed198 enrolled 18 charts 1 FDA
NCT01572922 2019-06-11Massive Iron Deposit AssessmentSt. Jude Children's Research HospitalPhase NA Completed142 enrolled 15 charts